A novel heterozygous mutation in the insulin receptor gene presenting with type A severe insulin resistance syndrome

Arameh S. Aghababaie,Martha Ford-Adams,Charles R. Buchanan,Ved B. Arya,Kevin Colclough,Ritika R. Kapoor
DOI: https://doi.org/10.1515/jpem-2019-0503
2020-05-22
Journal of Pediatric Endocrinology and Metabolism
Abstract:Abstract Background Inherited severe insulin resistance syndromes (SIRS) are rare and can be caused by mutations in the insulin receptor gene ( INSR ). Case presentation A 12-year-old Jamaican girl with a BMI of 24.4 kg/m 2 presented with polyuria and polydipsia. A diagnosis of T1DM was made in view of hyperglycaemia (18 mmol/l), and elevated Hba1 C (9.9%), and insulin therapy was initiated. Over the next 2 years, she developed hirsutism and acanthosis nigricans, and had minimal insulin requirements with frequent post-prandial hypoglycaemia. In view of this, and her strong family history suggestive of a dominantly inherited type of diabetes, the diagnosis was revisited. Targeted next-generation sequencing (NGS) of the patient’s monogenic diabetes genes was performed. What is new? NGS revealed a novel heterozygous missense INSR variant, NM_000208.3:c.3471T>G, p.(His1157Gln), confirming a diagnosis of Type A SIRS. Conclusions Type A SIRS can be difficult to differentially diagnose due to the variable phenotype. Features of insulin resistance may be absent at initial presentation and may develop later during pubertal progress. Awareness of the clinical features and comprehensive genetic testing are essential to identify the condition.
pediatrics,endocrinology & metabolism
What problem does this paper attempt to address?